Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Empagliflozin (25mg) + Sitagliptin (100mg) Tablet
Dosage Form : Tablet
Packaging Type : Alu Alu
Packaging : 10*10
Price : ₹1/-
Emplozin S 25 Tablet is a combination medication used in the management of Type 2 diabetes mellitus. This tablet contains two active ingredients: Empagliflozin and Sitagliptin, which work together to improve blood glucose control when combined with diet and exercise.
Empagliflozin belongs to the class of medications known as SGLT2 inhibitors. It works by reducing the reabsorption of glucose in the kidneys, allowing more glucose to be excreted through urine, thus helping lower blood sugar levels. Sitagliptin, a DPP-4 inhibitor, increases the levels of incretin hormones that regulate insulin and glucagon secretion in response to meals. This dual action results in improved control of both fasting and post-meal blood sugar levels.
Emplozin S 25 Tablet is prescribed for patients with Type 2 diabetes who require more than one medication to effectively control their blood sugar levels. It may be used in combination with other antidiabetic agents, depending on the individual needs of the patient.
The combination therapy provides a complementary approach to diabetes management, addressing both insulin resistance and increased glucose production. This makes it an effective treatment option for patients who struggle with blood glucose control despite other interventions.
Common side effects include gastrointestinal discomfort, headaches, and respiratory infections. Serious side effects may include low blood sugar, pancreatitis, or kidney problems.
Indicated for the treatment of Type 2 diabetes mellitus in adults to improve blood glucose control, as part of a comprehensive treatment plan that includes diet and exercise.
Should not be used in patients with a history of severe kidney disease or diabetic ketoacidosis. Regular monitoring of renal function is recommended during treatment.
Store in a cool, dry place at room temperature, away from direct sunlight. Keep out of the reach of children.
Composition : Empagliflozin 10mg + Sitagliptin 100mg + Metformin 1000mg (extended release)
Composition : Empagliflozin 25mg + Sitagliptin 100mg + Metformin 1000mg (extended release)
Composition : Empagliflozin (10mg) + Linagliptin (5mg)
Composition : Empagliflozin (25mg) + Linagliptin (5mg)
Composition : Empagliflozin (10mg) Tablet
Composition : Empagliflozin (12.5mg) + Metformin (1000mg)
Composition : Empagliflozin (12.5mg) + Metformin (500mg)
Composition : Empagliflozin (5mg) + Metformin (500mg)
Composition : Empagliflozin (25mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation